Avant Brands Inc. (AVNT.TO)
CAD 0.53
(1.92%)
CAD 0.53
(1.92%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 4.83 Million CAD | -374.33% |
| 2022 | -3.08 Million CAD | -17.83% |
| 2021 | -9.3 Million CAD | -202.1% |
| 2020 | -5.07 Million CAD | 132.33% |
| 2019 | -7.29 Million CAD | 27.6% |
| 2018 | -11.92 Million CAD | -90375.1% |
| 2017 | - CAD | 105.67% |
| 2016 | -206.56 Thousand CAD | -503.14% |
| 2015 | 51.23 Thousand CAD | 107.88% |
| 2014 | -650.18 Thousand CAD | -289.27% |
| 2013 | -167.02 Thousand CAD | -998.86% |
| 2012 | -15.2 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -240 Thousand CAD | 63.75% |
| 2024 Q2 | -1.55 Million CAD | -79.27% |
| 2024 Q3 | -2.51 Million CAD | -64.34% |
| 2023 Q4 | -1.1 Million CAD | -130.23% |
| 2023 Q1 | 1.45 Million CAD | 243.76% |
| 2023 FY | - CAD | -374.33% |
| 2023 Q2 | 1.49 Million CAD | 2.82% |
| 2023 Q3 | 3.64 Million CAD | 144.14% |
| 2022 FY | - CAD | -17.83% |
| 2022 Q3 | 848 Thousand CAD | 127.69% |
| 2022 Q4 | -1.01 Million CAD | -219.1% |
| 2022 Q1 | 275 Thousand CAD | 113.69% |
| 2022 Q2 | -3.06 Million CAD | -1213.45% |
| 2021 Q3 | -2.25 Million CAD | -513.97% |
| 2021 FY | - CAD | -202.1% |
| 2021 Q4 | -2 Million CAD | 10.79% |
| 2021 Q2 | 544 Thousand CAD | -54.13% |
| 2021 Q1 | 1.18 Million CAD | -55.76% |
| 2020 FY | - CAD | 132.33% |
| 2020 Q1 | -480 Thousand CAD | 76.42% |
| 2020 Q2 | 176 Thousand CAD | 136.67% |
| 2020 Q3 | 385 Thousand CAD | 118.75% |
| 2020 Q4 | 2.68 Million CAD | 596.36% |
| 2019 Q3 | -1.45 Million CAD | 26.21% |
| 2019 Q1 | -2.2 Million CAD | 58.73% |
| 2019 Q2 | -1.96 Million CAD | 11.02% |
| 2019 Q4 | -2.03 Million CAD | -40.41% |
| 2019 FY | - CAD | 27.6% |
| 2018 Q2 | -1.48 Million CAD | -19685.35% |
| 2018 Q3 | -2.2 Million CAD | -48.0% |
| 2018 FY | - CAD | -90375.1% |
| 2018 Q4 | -5.35 Million CAD | -142.73% |
| 2018 Q1 | -7529.00 CAD | -120.95% |
| 2017 Q1 | -3110.00 CAD | 27.1% |
| 2017 Q4 | 35.94 Thousand CAD | 206.63% |
| 2017 Q3 | -33.71 Thousand CAD | -1544.39% |
| 2017 Q2 | -2050.00 CAD | 34.08% |
| 2017 FY | - CAD | 105.67% |
| 2016 FY | - CAD | -503.14% |
| 2016 Q2 | -7885.00 CAD | -327.23% |
| 2016 Q1 | 3470.00 CAD | -97.44% |
| 2016 Q4 | -4266.00 CAD | 35.89% |
| 2016 Q3 | -6654.00 CAD | 15.61% |
| 2015 FY | - CAD | 107.88% |
| 2015 Q3 | 35.69 Thousand CAD | 129.79% |
| 2015 Q1 | -5980.00 CAD | -101.34% |
| 2015 Q2 | -119.8 Thousand CAD | -1903.43% |
| 2015 Q4 | 135.49 Thousand CAD | 279.63% |
| 2014 Q3 | 66.82 Thousand CAD | 117.4% |
| 2014 Q1 | 56.65 Thousand CAD | 712.09% |
| 2014 FY | - CAD | -289.27% |
| 2014 Q4 | 446.76 Thousand CAD | 568.56% |
| 2014 Q2 | 30.73 Thousand CAD | -45.75% |
| 2013 Q1 | -2095.00 CAD | 0.0% |
| 2013 FY | - CAD | -998.86% |
| 2013 Q2 | - CAD | 100.0% |
| 2013 Q3 | -23.32 Thousand CAD | 0.0% |
| 2013 Q4 | -9256.00 CAD | 60.32% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aurora Cannabis Inc. | 20.47 Million CAD | 76.38% |
| Avicanna Inc. | -7.35 Million CAD | 165.747% |
| Cardiol Therapeutics Inc. | -27.87 Million CAD | 117.346% |
| Crescita Therapeutics Inc. | 45 Thousand CAD | -10646.667% |
| Knight Therapeutics Inc. | 40.89 Million CAD | 88.175% |
| MediPharm Labs Corp. | -10.47 Million CAD | 146.154% |
| OrganiGram Holdings Inc. | -207.61 Million CAD | 102.329% |
| Canopy Growth Corporation | -312.82 Million CAD | 101.546% |
| Willow Biosciences Inc. | -11.06 Million CAD | 143.721% |
| Auxly Cannabis Group Inc. | -10.82 Million CAD | 144.674% |